Professor Tim Denison FREng

Professor Tim Denison’s work is focused on engineering new ways to restore and enhance neurological function. 

Holding a Royal Academy of Engineering Chair in Emerging Technologies at the University of Oxford, Timothy leads research into physiologic closed-loop systems and bioelectronic therapies. His work integrates microelectronics, control systems and clinical neuroscience to develop technologies for conditions such as epilepsy, chronic pain and disorders of consciousness. 

Prior to joining Oxford, Timothy was Vice President of Research and Core Technology for Medtronic’s Restorative Therapies Group, where he led the development of next-generation neural interface and algorithm technologies. 

Timothy is also co-founder and Chief Engineer of Amber Therapeutics, applying bioelectronic systems to new clinical applications, and has been named on more than 100 US patents across fields including brain–computer interfaces and biomedical devices. 

Timothy was elected Fellow of the Royal Academy of Engineering in 2024, in recognition of his contributions to bioengineering and translational medical technology.